# FDA Inspection 1038516 - Teva Canada Limited - December 14, 2017

Source: https://www.keypedia.com/records/fda_inspections/teva-canada-limited/e2e9a601-3a5d-4ff1-a17e-05c99cdf5e8f
Source feed: FDA_Inspections

> FDA Inspection 1038516 for Teva Canada Limited on December 14, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1038516
- Company Name: Teva Canada Limited
- Inspection Date: 2017-12-14
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1224785 - 2023-11-10](https://www.keypedia.com/records/fda_inspections/teva-canada-limited/1a690dda-d0ce-48ed-a062-4b37c4f275f1)
- [FDA Inspection 1107481 - 2019-10-25](https://www.keypedia.com/records/fda_inspections/teva-canada-limited/aef8bac3-86c8-412a-a631-33bb71095ab3)
- [FDA Inspection 961307 - 2016-02-05](https://www.keypedia.com/records/fda_inspections/teva-canada-limited/00f4d4cd-0cee-45dc-a5b5-91e66280b966)
- [FDA Inspection 838128 - 2013-05-24](https://www.keypedia.com/records/fda_inspections/teva-canada-limited/cff709de-39b9-42d2-b83c-4062b15bd598)
- [FDA Inspection 749939 - 2011-09-29](https://www.keypedia.com/records/fda_inspections/teva-canada-limited/8a923681-b3c7-482d-bf2f-0a2031fc16bb)

Company: https://www.keypedia.com/companies/teva-canada-limited/6a370eba-92cd-4be4-81d9-c4f4033f3f4f

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c